MNOV
NASDAQ
$1.34
Medicinova Inc (MNOV)
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapies for the treatment of serious diseases with unmet medical needs in the United States. The company is headquartered in La Jolla, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $9 (+571.64%)
Market Cap
$65M
Free Cash Flow Yield
-14.53%
Beta (5Y)
0.47
Price Chart
Valuation
Market Cap$65M
Forward P/E8.53
P/S109.72
P/B1.66
Profitability
Total Revenue (TTM)$597K
Gross Profit (TTM)$48K
EBITDA-$13M
Operating Margin-1517%
EPS-$0.24
Financial Health
Free Cash Flow Yield-14.53%
Growth & Risk
EPS 5Y CAGR-1.18%
Revenue 5Y CAGR-31.65%
FCF 5Y CAGR-4.28%
Beta (5Y)0.47
Sharpe Ratio0.19